It also increases the release of Type 2 T helper cell cytokines and the extracellular signal-regulated kinase 2 (ERK2) signaling pathway, indicating that IL-6 promotes a tumor microenvironment for cancer cell proliferation [11]. Here, MAPK1 is linked to neoplasm.